BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1500 related articles for article (PubMed ID: 24430863)

  • 41. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve.
    Tran ND; Cedars MI; Rosen MP
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3609-14. PubMed ID: 21937624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
    Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between antral follicle count, blood serum concentration of anti-Müllerian hormone and fertility in mares.
    Traversari J; Aepli H; Knutti B; Lüttgenau J; Bruckmaier RM; Bollwein H
    Schweiz Arch Tierheilkd; 2019 Oct; 161(10):627-638. PubMed ID: 31586925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Which is more predictive ovarian sensitivity marker if there is discordance between serum anti-Müllerian hormone levels and antral follicle count? A retrospective analysis.
    Aslan K; Kasapoglu I; Cakir C; Koc M; Celenk MD; Ata B; Avci B; Uncu G
    J Obstet Gynaecol; 2022 Jul; 42(5):1461-1466. PubMed ID: 34996328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers.
    Jamil Z; Fatima SS; Ahmed K; Malik R
    Dis Markers; 2016; 2016():5246217. PubMed ID: 26977116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
    La Marca A; Volpe A
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation.
    Bruno-Gaston J; Jung J; Kumar T; Zarutskie P; Gibbons W; Devaraj S
    Clin Biochem; 2021 Sep; 95():34-40. PubMed ID: 34000288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
    Moolhuijsen LME; Visser JA
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
    Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
    Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.